Novartis
Executive Director, Portfolio & Pipeline Strategy
Novartis, East Hanover, New Jersey, us, 07936
Summary
This position will be based in East Hanover, NJ and will not have the ability to be located remotely. Please note that this role would not provide relocation, and only local candidates will be considered. This position will require up to 20% travel as defined by the business (domestic and/or international). The Executive Director, Portfolio and Early Pipeline Strategy Responsibilities
Lead a cross-functional team accountable for building the foundation for sustainable and profitable growth of the Therapeutic Area (TA) over the 10+ year horizon. Core areas include: forward-looking competitive readiness plans rooted in external and internal portfolio understanding; ensuring product/portfolio teams maintain readiness to anticipate and respond to external market changes and competitor activity in a legal and compliant manner. Provide input on assets to Strategy & Growth (S&G), Global Drug Development (GDD) and Biomedical Research to maximize commercial viability and launch value, including Life Cycle Management (LCM) planning for new indications, formulations and labels for in-line products, and Integrated Evidence Plans and LCM Plans for early pipeline assets (post IDPA until 6 months before FDP). Partner with US Business Development & Licensing (BD&L) and US Market Access to provide country-level input for BD&L evaluations (anytime post IDPA), including TPP development, stakeholder research, DC/IMB prep, etc. Support and/or lead strategic evaluations and initiatives that inform DA and TA strategies and provide input for TAL (e.g., white papers/position papers; identify competitive levers now and in the future; identify gaps in portfolio mix; identify emerging areas of unmet needs). Form and lead Early Asset Teams to transition assets from S&G to US Commercial 6 months before FDP, contributing to FDP submission package including commercial strategy and market shaping activities up to transition to a full IPST. About The Role
Key Responsibilities
Perform strategic assessments of select competitor activities, including market situation analysis, strategic forecasting, benchmarking, and developing cross-functional competitive response plans in a legal and compliant manner. Monitor and benchmark strategic plans and key competitive developments to provide early warning for threats and opportunities, enabling successful implementation of prioritized initiatives. Surveil core Disease Area healthcare and macroeconomic environment, including policy and regulatory factors, to identify threats and opportunities relevant to US planning and future portfolio growth. Design and execute competitive planning initiatives (competitive simulations) for key products, ensure integrity of competitive intelligence activities through coordination with team members and external vendors. Lead lifecycle management planning across the TA portfolio to maximize long-term asset value. Collaborate with cross-functional partners (Medical Affairs, GDD, Strategy & Growth, Novartis Technical Operations, Regulatory, Finance, Supply Chain, Trade, Market Access) to realize LCM priorities; manage risks and escalation; coordinate with peers and vendors on forecasts and cost projections. Liaise with Market Access, Medical, BD&L, M&A, Biomedical Research, GDD and S&G to develop US go/no-go positions on asset/company targets. Inform commercialization strategies for assets in pre-IDPA and later stages (pre-FDP) to support US-centric product profile development and transition to IPSTs as appropriate. Develop center of excellence capabilities within the team. Essential Requirements
Minimum 10 years of commercial experience with multiple functional experience (ideally including new products/pipeline/LCM) in a pharmaceutical, biotech, healthcare, or consulting environment, including at least 2 different cross-functional roles/experience. Recent US market experience with product launches and lifecycle stages. Experience partnering with Medical Affairs and GDD to inform strategic choices. High degree of autonomy, ability to work in a dynamic environment with creative problem-solving and industry knowledge. Portfolio approach with experience uncovering and implementing innovative strategies in a competitive marketplace. Ability to lead and maintain readiness excellence across the organization. The pay range for this position at commencement of employment is expected to be between $225,400.00 and $418,600.00 a year; however, salary ranges may adjust during the period. Final pay determinations depend on factors including location, experience, knowledge, skills and abilities. The total compensation package may include a sign-on bonus, RSUs, discretionary awards, and a full range of benefits (including 401(k) eligibility and various paid time off). If hired, the employee will be in an “at-will” position with the company reserving the right to modify base salary and other compensation programs at any time, including for performance or market factors. EEO Statement
The company is an equal opportunity employer. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. Accessibility & Reasonable Accommodations
We are committed to providing reasonable accommodations to individuals with disabilities. If you need an accommodation for any part of the application process or to perform essential job functions, please contact us with your request and include the job requisition number.
#J-18808-Ljbffr
This position will be based in East Hanover, NJ and will not have the ability to be located remotely. Please note that this role would not provide relocation, and only local candidates will be considered. This position will require up to 20% travel as defined by the business (domestic and/or international). The Executive Director, Portfolio and Early Pipeline Strategy Responsibilities
Lead a cross-functional team accountable for building the foundation for sustainable and profitable growth of the Therapeutic Area (TA) over the 10+ year horizon. Core areas include: forward-looking competitive readiness plans rooted in external and internal portfolio understanding; ensuring product/portfolio teams maintain readiness to anticipate and respond to external market changes and competitor activity in a legal and compliant manner. Provide input on assets to Strategy & Growth (S&G), Global Drug Development (GDD) and Biomedical Research to maximize commercial viability and launch value, including Life Cycle Management (LCM) planning for new indications, formulations and labels for in-line products, and Integrated Evidence Plans and LCM Plans for early pipeline assets (post IDPA until 6 months before FDP). Partner with US Business Development & Licensing (BD&L) and US Market Access to provide country-level input for BD&L evaluations (anytime post IDPA), including TPP development, stakeholder research, DC/IMB prep, etc. Support and/or lead strategic evaluations and initiatives that inform DA and TA strategies and provide input for TAL (e.g., white papers/position papers; identify competitive levers now and in the future; identify gaps in portfolio mix; identify emerging areas of unmet needs). Form and lead Early Asset Teams to transition assets from S&G to US Commercial 6 months before FDP, contributing to FDP submission package including commercial strategy and market shaping activities up to transition to a full IPST. About The Role
Key Responsibilities
Perform strategic assessments of select competitor activities, including market situation analysis, strategic forecasting, benchmarking, and developing cross-functional competitive response plans in a legal and compliant manner. Monitor and benchmark strategic plans and key competitive developments to provide early warning for threats and opportunities, enabling successful implementation of prioritized initiatives. Surveil core Disease Area healthcare and macroeconomic environment, including policy and regulatory factors, to identify threats and opportunities relevant to US planning and future portfolio growth. Design and execute competitive planning initiatives (competitive simulations) for key products, ensure integrity of competitive intelligence activities through coordination with team members and external vendors. Lead lifecycle management planning across the TA portfolio to maximize long-term asset value. Collaborate with cross-functional partners (Medical Affairs, GDD, Strategy & Growth, Novartis Technical Operations, Regulatory, Finance, Supply Chain, Trade, Market Access) to realize LCM priorities; manage risks and escalation; coordinate with peers and vendors on forecasts and cost projections. Liaise with Market Access, Medical, BD&L, M&A, Biomedical Research, GDD and S&G to develop US go/no-go positions on asset/company targets. Inform commercialization strategies for assets in pre-IDPA and later stages (pre-FDP) to support US-centric product profile development and transition to IPSTs as appropriate. Develop center of excellence capabilities within the team. Essential Requirements
Minimum 10 years of commercial experience with multiple functional experience (ideally including new products/pipeline/LCM) in a pharmaceutical, biotech, healthcare, or consulting environment, including at least 2 different cross-functional roles/experience. Recent US market experience with product launches and lifecycle stages. Experience partnering with Medical Affairs and GDD to inform strategic choices. High degree of autonomy, ability to work in a dynamic environment with creative problem-solving and industry knowledge. Portfolio approach with experience uncovering and implementing innovative strategies in a competitive marketplace. Ability to lead and maintain readiness excellence across the organization. The pay range for this position at commencement of employment is expected to be between $225,400.00 and $418,600.00 a year; however, salary ranges may adjust during the period. Final pay determinations depend on factors including location, experience, knowledge, skills and abilities. The total compensation package may include a sign-on bonus, RSUs, discretionary awards, and a full range of benefits (including 401(k) eligibility and various paid time off). If hired, the employee will be in an “at-will” position with the company reserving the right to modify base salary and other compensation programs at any time, including for performance or market factors. EEO Statement
The company is an equal opportunity employer. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. Accessibility & Reasonable Accommodations
We are committed to providing reasonable accommodations to individuals with disabilities. If you need an accommodation for any part of the application process or to perform essential job functions, please contact us with your request and include the job requisition number.
#J-18808-Ljbffr